Type 2 diabetes mellitus compromises the survival of diffuse large B-cell lymphoma patients treated with (R)-CHOP – the PLRG report

Comorbidities impair the prognosis of diffuse large B-cell lymphoma (DLBCL). Type 2 diabetes mellitus (DMT2) increases the risk of other comorbidities, e.g., heart failure (HF). Thus, we hypothesized that pre-existing DMT2 may negatively affect the outcome of DLBCL. To verify this, DLBCL patients tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Drozd-Sokolowska, Joanna, Zaucha, Jan Maciej, Biecek, Przemyslaw, Giza, Agnieszka, Kobylinska, Katarzyna, Joks, Monika, Wrobel, Tomasz, Kumiega, Beata, Knopinska-Posluszny, Wanda, Spychalowicz, Wojciech, Romejko-Jarosinska, Joanna, Fischer, Joanna, Wiktor-Jedrzejczak, Wieslaw, Dlugosz-Danecka, Monika, Giebel, Sebastian, Jurczak, Wojciech
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044262/
https://www.ncbi.nlm.nih.gov/pubmed/32103128
http://dx.doi.org/10.1038/s41598-020-60565-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044262/
https://www.ncbi.nlm.nih.gov/pubmed/32103128
http://dx.doi.org/10.1038/s41598-020-60565-7

Ejemplares similares